The Utility of EUS-FNA to Determine Surgical Candidacy in Patients with Pancreatic Cancer after Neoadjuvant Therapy
ConclusionsIn this series of patients with BRPC or LAPC and persistent PSTC after downstaging neoadjuvant treatment, EUS-FNA accurately determined surgical resectability and should be considered as part of the evaluation of such patients.
Source: Journal of Gastrointestinal Surgery - Category: Surgery Source Type: research
More News: Borderline Tumor | Cancer | Cancer & Oncology | Cytology | Gastroenterology | Neoadjuvant Therapy | Pancreas | Pancreatic Cancer | Pathology | Study | Surgery